Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Cathflo Activase (alteplase) was approved
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
Biotechnology | FDA | HIV | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
Pathogenesis was acquired by Chiron for $660 million
On Sept. 22, 2000, Pathogenesis was acquired by Emeryville, California-based Chiron for $660 million or $38.50 per share….
Stanford researchers discovered hereditary arthritis gene
On Jul. 11, 2000, Stanford researchers announced they had identified a substance commonly added to toothpaste to prevent…
Genentech drug TNKase (tenecteplase) was approved
On June 2, 2000, the U.S. Food and Drug Administration announced it had approved Genentech’s drug TNKaseﾮ (tenecteplase)….
Stanford researchers solved the structure of the RNA polymerase protein
On Apr. 24, 2000, Stanford researchers announced they have solved the structure of the RNA polymerase protein, one…
The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower
On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….
The Stanford Hospital Center for Clinical Sciences Research building opened
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…
QB 3 was founded as the University of California’s hub for innovation and entrepreneurship in life science
In 2000, QB3 founded as the University of California’s hub for innovation and entrepreneurship in life science, with…
Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
The University of California, Riverside Center for Nanoscale Science and Engineering was established
In 2000, the University of California, Riverside Center for Nanoscale Science and Engineering was established to capitalize on…
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Targretin to treat certain T-cell lymphomas
On Dec. 29, 1999, the U.S. Food and Drug Administration (FDA) approved Bexarotene (Targretin) to treat cutaneous T-cell…
University of Washington announced the departure of Leroy Hood to establish a new instutute
On Dec. 13, 1999, the University of Washington (UW) announced that Dr. Leroy Hood, chair of the Department…
The Buck Institute for Research on Aging opened its doors
On Sept. 30, 1999, the Buck Institute for Research on Aging, named for Marin County philanthropists Leonard and…
Stanford researchers discovered a genetic mutation that causes narcolepsy
On Aug. 11, 1999, researchers led by Stanford’s Emmanuel Mignot, MD, PhD, associate professor of psychiatry, used a…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…
The University of Southern California received a $110 million gift and was renamed the Keck School of Medicine
On Jul. 29, 1999, the University of Southern California (USC) announced that it had received a gift of…
George Rathmann was named the first recipient of the Biotechnology Heritage Award
On May 17, 1999, George Rathmann, Chair of Bothell-based ICOS Corp. and Chair Emeritus of Amgen, was named…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
UCSF Cancer Research Institute received NCI Comprehensive Cancer Center designation
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Livermore National Lab work was completed on the mouse genome as part of Laboratory efforts in comparative genomics
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
The Del E. Webb Center for Neuroscience and Aging was established at The Burnham Institute
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
University of California at Berkeley announced five-year, $25 million research partnership with Novartis
On Nov. 23, 1998, The University of California, Berkeley and the Novartis Agricultural Discovery Institute announced that they…
Louis J. Ignarro was awarded Nobel Prize in Physiology or Medicine
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…